VU University Medical Center, Amsterdam, the Netherlands
Centre for Human Drug Research, Leiden, the Netherlands.
Diabetes Care. 2017 Apr;40(4):583-590. doi: 10.2337/dc16-1690. Epub 2017 Feb 15.
This study investigated whether the relationship between neuropathy and microvascular dysfunction in patients with type 2 diabetes is independent of diabetes-related factors. For this purpose, we compared skin microvascular function in patients with type 2 diabetes with that of patients with cryptogenic axonal polyneuropathy (CAP), a polyneuropathy of unknown etiology.
Cross-sectional information was collected from 16 healthy controls (HCs), 16 patients with CAP, 15 patients with type 2 diabetes with polyneuropathy (DPN), and 11 patients with type 2 diabetes without polyneuropathy. Axonal degeneration was assessed with skin biopsy and nerve conduction studies. Microvascular skin vasodilation was measured using laser Doppler fluxmetry combined with iontophoresis of acetylcholine (ACh) and sodium nitroprusside (SNP).
Patients with CAP and DPN demonstrated a similar decrease in intraepidermal nerve fiber density and sural sensory nerve action potential compared with HCs. The vasodilator response to ACh was similar among patients with CAP (relative mean difference based on log values 13.3%; 95% CI -35.0 to 97.7%; = 0.652) but was lower in the patients with diabetes with neuropathy (157.5%; 42.0-366.7%; = 0.003) and without neuropathy (174.2%; 44.2-421.3%; = 0.003) compared with HCs. No significant differences were found between the groups of patients with diabetes ( = 0.845). The vasodilator response to SNP was not significantly different among the groups ( = 0.082).
In this study, endothelium-dependent vasodilation was reduced in patients with type 2 diabetes regardless of the presence of polyneuropathy, whereas microvascular vasodilation was normal in patients with CAP. These data suggest that in type 2 diabetes, neuropathy does not contribute to impaired microvascular endothelium-dependent vasodilation and vice versa. In addition, this study suggests that impaired microvascular vasodilation does not contribute to CAP.
本研究旨在探讨 2 型糖尿病患者神经病变与微血管功能障碍之间的关系是否独立于糖尿病相关因素。为此,我们比较了 2 型糖尿病患者与隐源性轴索性多发性神经病(CAP)患者的皮肤微血管功能。CAP 是一种病因不明的多发性神经病。
本研究收集了 16 名健康对照者(HCs)、16 名 CAP 患者、15 名 2 型糖尿病合并多发性神经病(DPN)患者和 11 名 2 型糖尿病无多发性神经病患者的横断面资料。通过皮肤活检和神经传导研究评估轴索变性。使用激光多普勒流量测量法结合乙酰胆碱(ACh)和硝普钠(SNP)离子电渗法测量微血管皮肤血管扩张。
与 HCs 相比,CAP 和 DPN 患者的表皮内神经纤维密度和腓肠神经感觉神经动作电位均明显下降。CAP 患者的 ACh 血管扩张反应相似(基于对数的相对平均差异 13.3%;95%CI-35.0 至 97.7%; = 0.652),但糖尿病伴神经病变患者(157.5%;42.0-366.7%; = 0.003)和无神经病变患者(174.2%;44.2-421.3%; = 0.003)的 ACh 血管扩张反应较低。糖尿病患者组之间无显著差异( = 0.845)。各组之间 SNP 的血管扩张反应无显著差异( = 0.082)。
在本研究中,2 型糖尿病患者无论是否存在多发性神经病,内皮依赖性血管舒张均降低,而 CAP 患者的微血管血管舒张正常。这些数据表明,在 2 型糖尿病中,神经病变不会导致微血管内皮依赖性血管舒张受损,反之亦然。此外,本研究表明,微血管血管舒张受损不会导致 CAP。